| Asset | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Equity | 95.47% | 96.90% | 97.89% | 97.09% | 97.20% | 97.57% |
| Debt | 4.32% | 3.19% | 1.91% | 2.93% | 3.56% | 2.24% |
| Others (incl. cash) | 0.21% | -0.09% | 0.20% | -0.02% | -0.76% | 0.19% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 60,898 | 12.12 | 10.86% | 0.00% |
| Divis Laboratories Ltd. | Healthcare | 14,339 | 11.55 | 10.35% | 1.21%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 20,440 | 10.47 | 9.38% | 6.80%↑ |
| Aster DM Quality Care Ltd. | Healthcare | 84,379 | 6.94 | 6.21% | -0.20%↓ |
| Max Healthcare Institute Ltd. | Healthcare | 59,564 | 6.54 | 5.86% | -0.66%↓ |
| Ajanta Pharma Ltd. | Healthcare | 16,765 | 5.81 | 5.20% | -0.36%↓ |
| Mankind Pharma Ltd. | Healthcare | 21,045 | 5.2 | 4.66% | -0.53%↓ |
| Dr. Lal Pathlabs Ltd. | Healthcare | 23,732 | 4.52 | 4.05% | 0.95%↑ |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 52,247 | 4.2 | 3.77% | -0.35%↓ |
| Rubicon Research Ltd. | Healthcare | 27,590 | 4.11 | 3.68% | -0.31%↓ |
| Abbott India Ltd. | Healthcare | 1,298 | 3.61 | 3.23% | 0.67%↑ |
| Neuland Laboratories Ltd. | Healthcare | 1,774 | 3.38 | 3.03% | -0.16%↓ |
| Navin Fluorine International Ltd. | Chemicals | 4,152 | 3.14 | 2.81% | -0.28%↓ |
| Sai Life Sciences Ltd. | Healthcare | 21,756 | 2.86 | 2.56% | -0.04%↓ |
| Cipla Ltd. | Healthcare | 18,111 | 2.67 | 2.39% | -0.18%↓ |
| Pfizer Ltd. | Healthcare | 5,215 | 2.52 | 2.25% | 0.60%↑ |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 74,950 | 2.48 | 2.23% | - |
| Anthem Biosciences Ltd. | Healthcare | 27,457 | 2.22 | 1.99% | -0.06%↓ |
| Global Health Ltd. | Healthcare | 14,551 | 2.05 | 1.83% | -0.02%↓ |
| Zydus Lifesciences Ltd. | Healthcare | 13,355 | 1.5 | 1.35% | -0.09%↓ |
| Sector | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 90.61% | 91.64% | 91.00% | 90.18% | 90.31% | 90.73% |
| Chemicals | 2.81% | 3.09% | 3.10% | 3.06% | 3.00% | 2.81% |
| Insurance | 0.89% | 1.03% | 1.15% | 1.17% | 1.23% | 1.26% |
| Consumer Discretionary | 0.68% | 0.67% | 0.74% | 0.75% | 0.79% | 0.78% |
| Services | 0.48% | 0.47% | 1.90% | 1.93% | 1.87% | 1.99% |
20.5 / 100
Weighted average Value score is 20.5. This indicates that portfolio is relatively overvalued using composite of value measures.
68.4 / 100
Weighted average Price Momentum score is 68.4. This indicates that portfolio has average momentum using composite of momentum measures.
80.9 / 100
Weighted average Quality score is 80.9. This indicates that portfolio has high quality using composite of quality measures.
63.6 / 100
Weighted average QVM score is 63.6. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
